OBJECTIVES: On-site screening and same-day treatment of maternal syphilis in underresourced settings can avert greater numbers of congenital syphilis cases, but health outcomes and associated costs must be evaluated jointly. METHODS: We used decision analysis to estimate the incremental cost-effectiveness of two on-site antenatal syphilis screening strategies to avert congenital infections-qualitative RPR (on-site RPR) and treponemal immunochromatographic strip assay (on-site ICS)-compared to the current practice (off-site RPR/TPHA). FINDINGS: With antenatal active syphilis prevalence of 6.3%, the incremental cost-effectiveness of on-site ICS in averting congenital infections was estimated to be USD104, averting 82% of cases expected in absence of a program. The incremental cost-effectiveness of off-site RPR/TPHA was USD82 but would avert only 55% of congenital syphilis cases. On-site RPR was dominated by the other screening strategies. CONCLUSIONS: In settings of high maternal syphilis prevalence, on-site antenatal screening with ICS is a cost-effective approach to reduce the incidence of congenital syphilis.
OBJECTIVES: On-site screening and same-day treatment of maternal syphilis in underresourced settings can avert greater numbers of congenital syphilis cases, but health outcomes and associated costs must be evaluated jointly. METHODS: We used decision analysis to estimate the incremental cost-effectiveness of two on-site antenatal syphilis screening strategies to avert congenital infections-qualitative RPR (on-site RPR) and treponemal immunochromatographic strip assay (on-site ICS)-compared to the current practice (off-site RPR/TPHA). FINDINGS: With antenatal active syphilis prevalence of 6.3%, the incremental cost-effectiveness of on-site ICS in averting congenital infections was estimated to be USD104, averting 82% of cases expected in absence of a program. The incremental cost-effectiveness of off-site RPR/TPHA was USD82 but would avert only 55% of congenital syphilis cases. On-site RPR was dominated by the other screening strategies. CONCLUSIONS: In settings of high maternal syphilis prevalence, on-site antenatal screening with ICS is a cost-effective approach to reduce the incidence of congenital syphilis.
Authors: Arnold R Castro; Javan Esfandiari; Shailendra Kumar; Matthew Ashton; Susan E Kikkert; Mahin M Park; Ronald C Ballard Journal: J Clin Microbiol Date: 2010-09-29 Impact factor: 5.948
Authors: Katharine D Shelley; Éimhín M Ansbro; Alexander Tshaka Ncube; Sedona Sweeney; Colette Fleischer; Grace Tembo Mumba; Michelle M Gill; Susan Strasser; Rosanna W Peeling; Fern Terris-Prestholt Journal: PLoS One Date: 2015-05-13 Impact factor: 3.240
Authors: Rodrigo Cerda; Freddy Perez; Rosa Maria S M Domingues; Paula M Luz; Beatriz Grinsztejn; Valdilea G Veloso; Sonja Caffe; Jordan A Francke; Kenneth A Freedberg; Andrea L Ciaranello Journal: Open Forum Infect Dis Date: 2015-05-22 Impact factor: 3.835
Authors: Éimhín M Ansbro; Michelle M Gill; Joanna Reynolds; Katharine D Shelley; Susan Strasser; Tabitha Sripipatana; Alexander Tshaka Ncube; Grace Tembo Mumba; Fern Terris-Prestholt; Rosanna W Peeling; David Mabey Journal: PLoS One Date: 2015-06-01 Impact factor: 3.240
Authors: Nicholas X Tan; Chara Rydzak; Li-Gang Yang; Peter Vickerman; Bin Yang; Rosanna W Peeling; Sarah Hawkes; Xiang-Sheng Chen; Joseph D Tucker Journal: PLoS Med Date: 2013-01-22 Impact factor: 11.069
Authors: Olga P M Saweri; Neha Batura; Rabiah Al Adawiyah; Louise M Causer; William S Pomat; Andrew J Vallely; Virginia Wiseman Journal: PLoS One Date: 2021-06-17 Impact factor: 3.240